遗传学和基因组学到诊所:前面还有很长的路要走
1Howard Hughes Medical Institute, Department of Internal Medicine, and the Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA. ginsburg@umich.edu
Cell
|October 4, 2011
概括
基因组技术为人类疾病提供了大量的遗传信息,为更好的治疗提供了希望. 本综述评估了目前遗传学和基因组学对医学的贡献以及未来的前景.
科学领域:
- 基因组学就是基因组学.
- 医学遗传学 医学遗传学
- 临床实践 临床实践
背景情况:
- 基因组技术的进步已经产生了大量关于人类疾病遗传基础的数据.
- 这导致人们对开发新型治疗策略的期望显著.
研究的目的:
- 评估目前遗传学和基因组学对临床实践的影响.
- 预测这些领域在医学中的未来潜力.
主要方法:
- 审查当前文献和遗传和基因组数据的临床应用.
- 对现有和新兴趋势进行基于前景的分析.
主要成果:
- 遗传学和基因组学已经开始影响诊断方法和个性化医学.
- 早期的成功包括针对特定遗传疾病的向疗法.
结论:
- 遗传学和基因组学为彻底改变医疗保健提供了巨大的希望.
- 持续的研究和整合对于实现未来的治疗进步至关重要.
更多相关视频
相关概念视频
Genomics
35.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.5K
Next-generation Sequencing
87.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.9K
Genetic Screens
4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
Principles of Pharmacogenetics: Types of Genetic Variants
138
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121


